Sotac Pharmaceuticals Ltd.
NSE: SOTAC
₹90.05
₹0.00 (0.00%)As on 28-Aug-2026 11:41IST
Market cap
₹100 Cr
Revenue (TTM)
₹97 Cr
P/E Ratio
17.3
P/B Ratio
1.8
Div. Yield
0.2 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹9 Cr
-
ROE
18.8 %
-
ROCE
16.4 %
-
Industry P/E
39.7
-
EV/EBITDA
7.8
-
Debt to Equity
0.8
-
Book Value
₹48.2
-
EPS
₹7.3
-
Face value
10
-
Shares outstanding
11,050,000
6 Years Aggregate
CFO
₹-6.16 Cr
EBITDA
₹38.77 Cr
Net Profit
₹15.74 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sotac Pharmaceuticals
| -26.8 | -- | -18.9 | -34.5 | -11.1 | -- | -- |
|
BSE Healthcare
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Sotac Pharmaceuticals
| 11.1 | -7.3 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sotac Pharmaceuticals
|
90.1 | 99.5 | 97.0 | 9.3 | -- | 18.8 | 17.3 | 1.8 |
| 3,274.0 | 26,632.7 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69 | 15.4 | |
| 814.3 | 15,973.7 | 7,784.0 | 688.5 | 10.6 | 14 | 23 | 2.7 | |
| 450.2 | 17,236.0 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.2 | 20,766.6 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.4 | 4.2 | |
| 1,534.1 | 17,498.5 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.6 | 28,857.0 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,802.0 | 30,013.4 | 1,935.8 | 288.2 | 20.6 | 29.8 | 104.1 | 22.4 | |
| 403.5 | 16,330.4 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.9 | 3.4 | |
| 1,973.6 | 32,416.4 | 3,564.0 | 414.0 | 15.3 | 8.4 | 79.3 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sotac Pharmaceuticals
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
2015
-
Chairman
Sharadkumar Dashrathbhai Patel
-
Managing Director
Sharadkumar Dashrathbhai Patel
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Sotac Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Sotac Pharmaceuticals
What is the current share price of Sotac Pharmaceuticals Ltd Today?
The share price of Sotac Pharmaceuticals Ltd is ₹90.05 (NSE) as of 28-Aug-2026 11:41 IST. Sotac Pharmaceuticals Ltd has given a return of -11.06% in the last 3 years.
What is the current PB & PE ratio of Sotac Pharmaceuticals Ltd?
The P/E ratio of Sotac Pharmaceuticals Ltd is 17.25 times as on 20-Aug-2026, a 57 discount to its peers’ median range of 39.70 times.
The P/B ratio of Sotac Pharmaceuticals Ltd is 1.79 times as on 20-Aug-2026, a 52 discount to its peers’ median range of 3.72 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
16.35 |
2.46 |
2024 |
31.23 |
2.95 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Sotac Pharmaceuticals Ltd?
The 52-week high and low of Sotac Pharmaceuticals Ltd are Rs 139.65 and Rs 0.00 as of 28-Aug-2026.
What is the market cap of Sotac Pharmaceuticals Ltd?
Sotac Pharmaceuticals Ltd has a market capitalisation of ₹ 100 Cr as on 20-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sotac Pharmaceuticals Ltd?
Before investing in Sotac Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.